<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain><z:mp ids='MP_0009563'>Dyskeratosis</z:mp> congenita is a congenital <z:e sem="disease" ids="C0559758" disease_type="Disease or Syndrome" abbrv="">multisystem disorder</z:e>, characterized by skin <z:hpo ids='HP_0001000'>pigmentation</z:hpo>, <z:hpo ids='HP_0008404'>dystrophic nails</z:hpo>, and <z:e sem="disease" ids="C0023531" disease_type="Neoplastic Process" abbrv="">leukoplakia</z:e> </plain></SENT>
<SENT sid="1" pm="."><plain>Hematologic abnormalities progressing to severe <z:hpo ids='HP_0001876'>pancytopenia</z:hpo> play a significant role in the poor prognosis of afflicted patients </plain></SENT>
<SENT sid="2" pm="."><plain>We report on a patient with <z:mp ids='MP_0009563'>dyskeratosis</z:mp> congenita and severe <z:hpo ids='HP_0001915'>aplastic anemia</z:hpo>, complicated by life threatening <z:e sem="disease" ids="C0021311,C0009450" disease_type="Disease or Syndrome" abbrv="">infection</z:e> </plain></SENT>
<SENT sid="3" pm="."><plain>The patient was treated with recombinant granulocyte-macrophage colony-stimulating factor </plain></SENT>
<SENT sid="4" pm="."><plain>This therapy resulted in a moderate and transient improvement in absolute neutrophil counts </plain></SENT>
<SENT sid="5" pm="."><plain>Current concepts regarding the pathogenesis and etiology of <z:mp ids='MP_0009563'>dyskeratosis</z:mp> congenita are discussed, while reviewing the available therapeutic options </plain></SENT>
</text></document>